ARALEZ PHARMACEUTICALS INC.
CIK 0001660719
Revenue (TTM)
—
Q1 May 2018
Net Income (TTM)
−$99.18M
−87.3% YoY
Q1 May 2018
EPS Diluted (TTM)
−$1.50
−83.8% YoY
Q1 May 2018
Gross Margin
—
Q1 May 2018
Operating Margin
—
Q1 May 2018
Net Margin
—
Q1 May 2018
Free Cash Flow (TTM)
−$30.68M
Q1 May 2018
Cash
$43.89M
Q1 May 2018
Total Debt
$274.57M
Q1 May 2018
Shares Outstanding
67.19M sh
Q1 May 2018
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.